MassHealth is transitioning coverage for anti-obesity drugs, designating Zepbound as the preferred option starting in January 2025, with Wegovy and Saxenda being discontinued for most adult members.
The most amazing thing, though, is how Amanda faces those challenges head-on, even when it comes to plateaus in her weight loss. After her latest surgery, Amanda lost weight steadily, and on a ...